Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$1.0 - $2.51 $2,206 - $5,537
-2,206 Reduced 12.46%
15,500 $37,000
Q4 2022

Feb 03, 2023

SELL
$1.16 - $2.42 $4,722 - $9,851
-4,071 Reduced 18.69%
17,706 $25,000
Q2 2022

Jul 28, 2022

SELL
$2.0 - $3.0 $8,000 - $12,000
-4,000 Reduced 15.52%
21,777 $45,000
Q1 2022

May 03, 2022

SELL
$2.9 - $3.47 $5,800 - $6,940
-2,000 Reduced 7.2%
25,777 $75,000
Q4 2021

Feb 10, 2022

SELL
$3.17 - $4.09 $158 - $204
-50 Reduced 0.18%
27,777 $89,000
Q3 2021

Nov 02, 2021

BUY
$3.01 - $3.77 $6,020 - $7,540
2,000 Added 7.74%
27,827 $99,000
Q2 2021

Aug 09, 2021

SELL
$2.86 - $3.61 $11,440 - $14,440
-4,000 Reduced 13.41%
25,827 $82,000
Q3 2020

Nov 05, 2020

BUY
$2.02 - $3.02 $6,060 - $9,060
3,000 Added 11.18%
29,827 $63,000
Q2 2020

Aug 10, 2020

BUY
$2.12 - $3.22 $10,600 - $16,100
5,000 Added 22.91%
26,827 $60,000
Q1 2020

May 05, 2020

BUY
$1.82 - $3.87 $5,460 - $11,610
3,000 Added 15.93%
21,827 $55,000
Q1 2019

Apr 23, 2019

BUY
$2.54 - $4.02 $7,620 - $12,059
3,000 Added 18.95%
18,827 $51,000
Q4 2018

Feb 07, 2019

BUY
$2.46 - $4.2 $7,380 - $12,600
3,000 Added 23.39%
15,827 $44,000
Q3 2018

Oct 12, 2018

BUY
$3.81 - $5.53 $3,810 - $5,530
1,000 Added 8.46%
12,827 $53,000
Q2 2018

Jul 30, 2018

SELL
$5.06 - $6.78 $5,894 - $7,898
-1,165 Reduced 8.97%
11,827 $61,000
Q1 2018

May 11, 2018

SELL
$5.43 - $8.36 $10,860 - $16,720
-2,000 Reduced 13.34%
12,992 $71,000
Q4 2017

Jan 30, 2018

BUY
$8.15 - $10.55 $8,150 - $10,550
1,000 Added 7.15%
14,992 $122,000
Q3 2017

Oct 23, 2017

BUY
$10.45 - $11.44 $10,450 - $11,440
1,000 Added 7.7%
13,992 $146,000
Q2 2017

Aug 07, 2017

BUY
N/A
12,992
12,992 $143,000

Others Institutions Holding ENZ

About ENZO BIOCHEM INC


  • Ticker ENZ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 48,720,500
  • Market Cap $33.1M
  • Description
  • Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...
More about ENZ
Track This Portfolio

Track Cutter & CO Brokerage, Inc. Portfolio

Follow Cutter & CO Brokerage, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.